Clinical Trials Logo

Clinical Trial Summary

Aromatherapy has been proven to be effective for treating patients with postoperative nausea and vomiting (PONV) after surgery, but few studies analyze its effect on preventing PONV. Most studies use aromatherapy once patients become nauseous, but this study will address a gap in the literature with relation to the effect of aromatherapy in the prevention of PONV.


Clinical Trial Description

The purpose of this pilot study is to determine if aromatherapy will prevent postoperative nausea and vomiting (PONV). Peppermint aromatherapy will be used preemptively to test for effectiveness, decreased PONV, and the ability to avoid anti-emetics. This study will seek to demonstrate that peppermint aromatherapy is a simple, cost effective way to prevent PONV after anesthesia. By decreasing the need for anti-emetics and incidence of PONV, patients may have a quicker recovery time and experience less side effects from anti-emetics, such as increased sedation. This problem is significant to patients and society as it may demonstrate that the inhalation of peppermint can ease PONV and decrease costs due to anti-emetics, wound dehiscence, and prolonged hospital stay. This study may lead to higher levels of patient satisfaction; if the patients are not nauseated they may be more satisfied with their care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03577496
Study type Interventional
Source The University of Texas Medical Branch, Galveston
Contact
Status Completed
Phase N/A
Start date June 15, 2018
Completion date December 15, 2018

See also
  Status Clinical Trial Phase
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04622618 - Optimal Dosing of Preoperative Gabapentin for Prevention of Postoperative Nausea and Vomiting Early Phase 1
Completed NCT03599427 - Added Value of Systemic Lidocaine on Postoperative Pain, Opiate Use and Nausea After Knee Arthroscopy Phase 4
Recruiting NCT05975385 - Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy N/A
Recruiting NCT04589429 - Adding Nalbuphine for Control of Intrathecal Morphine Pruritus Phase 2
Recruiting NCT04654429 - Does Higher OT Temperature and IV Ondansetron Reduce Incidence of PSS in Parturients? Phase 4
Completed NCT05947981 - Pre-operative 5% Dextrose Infusion & PONV N/A
Recruiting NCT06137976 - Surgeon Perception of Gastric Decompression at Time of Gynecologic Laparoscopy N/A
Not yet recruiting NCT06114277 - The Relationship Between Intraoperative ETCO2 Levels and Postoperative Pain and Nausea-Vomiting
Recruiting NCT04618146 - Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine. N/A
Active, not recruiting NCT03645239 - Post-operative Emesis and Pain Outcomes After Cesarean Delivery
Completed NCT04610398 - Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Hip Arthroscopy Phase 3
Completed NCT03130218 - Aromatherapy in Management of Postoperative Nausea in Post-Bariatric Surgery Patients N/A
Recruiting NCT06151912 - The Effect of Staple Line Reinforcement Procedures on Postoperative Nausea and Vomiting in Sleeve Gastrectomy N/A
Recruiting NCT04762381 - Dexamethasone and Robotic-assisted Hysterectomy N/A
Not yet recruiting NCT04442568 - Impact of ERAS in LSG N/A
Completed NCT03727607 - TIVA Versus Desfluran Anaesthesia in Patients Undergoing Bariatric Surgery Phase 2
Recruiting NCT06110416 - Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient N/A
Not yet recruiting NCT06137924 - Intraoperative Autonomic Neural Blockade Phase 3
Recruiting NCT06022705 - Evaluation of the Effect of APFEL Risk Score and Fasting Periods on Postoperative Nausea and/or Vomiting